pirifibrate

Also Known As:

(6-(hydroxymethyl)-2-pyridyl)methyl-2-(4-chlorophenoxy)-2-methyl-propionate hydrochloride; Bratenol; EL-466; Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, (6-(hydroxymethyl)-2-pyridinyl)methyl ester, hydrochloride

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

Hyperlipoproteinemias

01/01/1981 - "A new drug, pirifibrate, was investigated in a multicenter study of 100 patients with type IIa, IIb, or IV hyperlipoproteinemia (HLP). "
01/01/1981 - "Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations."
01/01/1980 - "Pirifibrate, a new hypolipemic substance, was studied in a multicenter trial for three months in 151 patients diagnosed as having type IIa, IIb or IV hyperlipoproteinemia (HLP). "
01/01/1980 - "Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study."
01/01/1980 - "Pirifibrate was given to 53 patients with type IIa, IIb or IV hyperlipoproteinemia (HLP), and the results of the first three months of treatment were evaluated. "